FDA OKs New Blood Cancer Drug

Friday, 08 Feb 2013 05:22 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
The Food and Drug Administration said Friday it approved a new drug from Celgene for patients with hard-to-treat multiple myeloma, a cancer of the blood.

The agency approved the pill Pomalyst for cases of the disease that have spread even after treatment with two other cancer drugs.

Multiple myeloma mainly affects older adults and kills about 10,700 people annually, according to the National Cancer Institute.

FDA noted that Pomalyst is the second drug approved for multiple myeloma in the past year. The agency approved Kyprolis from Onyx Pharmaceuticals Inc. in July 2012.

"Treatment for multiple myeloma is tailored to meet individual patient's needs, and today's approval provides an additional treatment option for patients who have not responded to other drugs," said Dr. Richard Pazdur, FDA's office director for cancer drugs, in a statement.

Obamacare: Massive New Rules Revealed for 2013

Pomalyst carries a boxed warning, the most serious type, alerting patients and doctors that the drug can cause severe birth defects in pregnant women and can cause blood clots.

Shares of Celgene Corp., based in Summit, N.J., rose $2.29, or 2.4 percent, to $100.13. The stock added 17 cents to $100.30 in after-hours trading.

© Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

One Part of Brain Doesn't Age, Researchers Say

Friday, 22 Aug 2014 16:29 PM

At least one part of an older person's brain can still process information as well as younger people, according to new r . . .

Eyelid Surgery Can Cure Migraines: Study

Friday, 22 Aug 2014 16:23 PM

Cosmetic eyelid surgery involving specific nerves may do more than improve your looks -- the procedure may also provide  . . .

Ebola 'Shadow Zones' Hide Disease: WHO

Friday, 22 Aug 2014 16:16 PM

The scale of the world's worst Ebola outbreak has been concealed by families hiding infected loved ones in their homes a . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved